Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Fennec Pharmaceuticals Inc. (FENC)

5.57   -0.05 (-0.89%) 06-26 23:21
Open: 5.6542 Pre. Close: 5.62
High: 5.69 Low: 5.55
Volume: 20,485 Market Cap: 145(M)
Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product PEDMARK, a formulation of Sodium Thiosulfate that has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.7 - 5.73 5.73 - 5.75
Low: 5.47 - 5.51 5.51 - 5.54
Close: 5.52 - 5.57 5.57 - 5.62

Technical analysis

as of: 2022-06-24 4:39:52 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 6.65     One year: 6.97
Support: Support1: 5.26    Support2: 4.37
Resistance: Resistance1: 5.69    Resistance2: 5.96
Pivot: 5.55
Moving Average: MA(5): 5.56     MA(20): 5.6
MA(100): 5.59     MA(250): 6.47
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 53.2     %D(3): 51.5
RSI: RSI(14): 47.8
52-week: High: 10.07  Low: 3.82
Average Vol(K): 3-Month: 28 (K)  10-Days: 28 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ FENC ] has closed below upper band by 44.1%. Bollinger Bands are 58.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Sat, 25 Jun 2022
Polyethylene Terephthalate Market Outlook 2022 And Growth By Top KeyPlayers – DuPont, FENC, Indorama Ventures, Jiangsu Sanfangxiang – Designer Women - Designer Women

Thu, 23 Jun 2022
Has Adherex Technologies (FENC) Outpaced Other Medical Stocks This Year? - Nasdaq

Tue, 21 Jun 2022
DBS Bank offers first blue loan in Taiwan to FENC - 台北時報

Tue, 14 Jun 2022
Fennec Announces Results of Annual Meeting - GlobeNewswire

Sun, 12 Jun 2022
India secures highly coveted spot at the FIFAe Nations Cup 2022 - Sportskeeda

Thu, 09 Jun 2022
Brokers Issue Forecasts for Fennec Pharmaceuticals Inc's FY2023 Earnings (NASDAQ:FENC) - MarketBeat

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 26 (M)
Shares Float 22 (M)
% Held by Insiders 17 (%)
% Held by Institutions 43.9 (%)
Shares Short 265 (K)
Shares Short P.Month 270 (K)

Stock Financials

EPS -0.63
EPS Est Next Qtl 0
EPS Est This Year -0.24
EPS Est Next Year -0.21
Book Value (p.s.) 0.47
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -42.2
Return on Equity (ttm) -87.1
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow -13 (M)
Levered Free Cash Flow -7 (M)

Stock Valuations

PE Ratio -8.85
PEG Ratio 0
Price to Book value 11.6
Price to Sales 0
Price to Cash Flow -10.76

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.